How Vertex Regained Its Footing on a Competitor's Bullish Report The pharmaceutical industry is often characterized by intense competition and high stakes, but sometimes companies can benefit from each other's progress.
This week's surprise rebound in Vertex Pharmaceuticals' stock price has raised questions about the relationship between competitors in this field.
Vertex stock rose on Tuesday following its strong second quarter report, while Otsuka announced promising data for its IgA nephropathy treatment, Voyxact.